Stein Gold, L. ., Eyerich, K. ., Sofen, H. ., Herranz, P. ., Kircik, L. ., Bewley, T. ., Wolf, E. ., Gallo, G. ., Ding, Y. ., Yang, F. E. ., Pau-Charles, I. . and Gooderham, M. . (2023) “Lebrikizumab Demonstrates Consistent Efficacy at 16 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis Regardless of Baseline Disease Severity”, SKIN The Journal of Cutaneous Medicine, 7(6), p. s274. doi: 10.25251/skin.7.supp.274.